Genesis Drug Discovery & Development Appoints Laura Sailor Veteran CRO Business Development Leader As Director Of Business Development.
HAMILTON, N.J., Sept. 16, 2021 /PRNewswire/ --Genesis Drug Discovery & Development (GD3), the contract research organization (CRO) arm of Genesis Biotechnology Group (GBG), has announced the appointment of Laura Sailor as its new Director of Business Development.